Centenial Surgical Suture Ltd vs Gujarat Kidney Super Speciality Ltd Stock Comparison
Centenial Surgical Suture Ltd vs Gujarat Kidney Super Speciality Ltd Stock Comparison
Last Updated on: Oct 25, 2026
Key Highlights
The Latest Trading Price of Centenial Surgical Suture Ltd is ₹ 67.95 as of 23 Oct 15:30
. The P/E Ratio of Centenial Surgical Suture Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Gujarat Kidney & Super Speciality Ltd changed from 51.4 on March 2026 to 51.4 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Centenial Surgical Suture Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Gujarat Kidney & Super Speciality Ltd changed from ₹ 798.29 crore on March 2026 to ₹ 798.29 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The revenue of Centenial Surgical Suture Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Gujarat Kidney & Super Speciality Ltd for the Jun '26 is ₹ 34.98 crore as compare to the Mar '26 revenue of ₹ 31.29 crore. This represent the growth of 11.79% The ebitda of Centenial Surgical Suture Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Gujarat Kidney & Super Speciality Ltd for the Jun '26 is ₹ 9.07 crore as compare to the Mar '26 ebitda of ₹ 7.01 crore. This represent the growth of 29.39% The net profit of Centenial Surgical Suture Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0%
The net profit of Gujarat Kidney & Super Speciality Ltd changed from ₹ 2.96 crore to ₹ 5.32 crore over 8 quarters. This represents a CAGR of 34.06%
The Dividend Payout of Centenial Surgical Suture Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Gujarat Kidney & Super Speciality Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About Centenial Surgical Suture Ltd
Incorporated in 1995, Centenial Surgical Suture Limited is engaged in the manufacture and sale of surgical sutures in India.
The company offers absorbable sutures that include natural and synthetic sutures and non absorbable sutures comprising needles for cardiovascular surgery, monofilament polyamide atraumatic needle suture combinations, monofilament stainless steel, and temporary pacemaker electrodes.
It also provides female urinary incontinency sets, titanium haemostatic clips for cardiovascular surgery, non absorbable.
Company leverages the expertise and application knowledge of the global suture requirements for cardiovascular sutures in particular, to bring advanced atraumatic needle product development to the Indian Surgeons.
Continuous innovation in the areas of design, research and development of atraumatic needle, simulation and validation, testing and services, are the key value creation driver for the Company.
About Gujarat Kidney & Super Speciality Ltd
Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre.
Subsequently, the Company name was changed to Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.
Further, Company' status was changed to a public limited company and the name of Company was changed to Gujarat Kidney and Super Speciality Limited' dated November 24, 2023 by the ROCs, Ahmedabad.
The Company operate a chain of mid-sized multispecialty healthcare institution and is engaged in providing comprehensive medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency care.
FAQs for the comparison of Centenial Surgical Suture Ltd and Gujarat Kidney & Super Speciality Ltd
Which company has a larger market capitalization, Centenial Surgical Suture Ltd or Gujarat Kidney & Super Speciality Ltd?
Market cap of Centenial Surgical Suture Ltd is 24 Cr while Market cap of Gujarat Kidney & Super Speciality Ltd is 1,395 Cr
What are the key factors driving the stock performance of Centenial Surgical Suture Ltd and Gujarat Kidney & Super Speciality Ltd?
The stock performance of Centenial Surgical Suture Ltd and Gujarat Kidney & Super Speciality Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Centenial Surgical Suture Ltd and Gujarat Kidney & Super Speciality Ltd?
As of October 25, 2026, the Centenial Surgical Suture Ltd stock price is INR ₹67.95. On the other hand, Gujarat Kidney & Super Speciality Ltd stock price is INR ₹176.95.
How do dividend payouts of Centenial Surgical Suture Ltd and Gujarat Kidney & Super Speciality Ltd compare?
To compare the dividend payouts of Centenial Surgical Suture Ltd and Gujarat Kidney & Super Speciality Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.